1-3 of 3
Authors: Carlos Galera
Sort by
Journal Article
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study Free
Jesús Troya and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 3, March 2024, Pages 595–607, https://doi.org/10.1093/jac/dkae011
Published: 24 January 2024
Journal Article
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice Open Access
Alejandro Gonzalez-Serna and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 10, October 2023, Pages 2591–2596, https://doi.org/10.1093/jac/dkad278
Published: 06 September 2023
Journal Article
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice Free
Marta Alvarez and others
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 6, June 2019, Pages 1693–1700, https://doi.org/10.1093/jac/dkz067
Published: 05 March 2019
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals